“Adverse events following the first dose of ChAdOx1 nCoV-19 (COVISHIELD) vaccine in the first phase of vaccine roll out in Nepal” (2021) Journal of Patan Academy of Health Sciences, 8(1), pp. 9–17. doi:10.3126/jpahs.v8i1.36242.